We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

2 hedge funds and large institutions have $442 invested in Avadel Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 202 closing their positions.

New
Increased
Maintained
Reduced
Closed

75.53% less ownership

Funds ownership: 75.53% → 0% (-76%)

99% less funds holding

Funds holding: 207 → 2 (-205)

100% less funds holding in top 10

Funds holding in top 10: 8 → 0 (-8)

100% less capital invested

Capital invested by funds: $1.6B → $442 (-$1.6B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 202

Holders
2
Holders Change
-205
Holders Change %
-99.03%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
202
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$152M
2
GJL
Gendell Jeffrey L
-$103M
3
WAM
Weiss Asset Management
Massachusetts
-$97.3M
4
TAL
TIG Advisors LLC
New York
-$83.2M
5
Tudor Investment Corp
Tudor Investment Corp
Connecticut
-$64.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
IA
1
IFP Advisors
Florida
$426 – – –
HNB
2
Huntington National Bank
Ohio
$16 – – –
BlackRock
3
BlackRock
New York
– -$152M -7,041,102 Closed
GJL
4
Gendell Jeffrey L
– -$103M -4,769,357 Closed
WAM
5
Weiss Asset Management
Massachusetts
– -$97.3M -4,515,114 Closed
TAL
6
TIG Advisors LLC
New York
– -$83.2M -3,859,122 Closed
Tudor Investment Corp
7
Tudor Investment Corp
Connecticut
– -$64.3M -2,983,541 Closed
Fidelity International
8
Fidelity International
Bermuda
– -$60.8M -2,822,777 Closed
VC
9
Vivo Capital
California
– -$57.8M -2,684,109 Closed
State Street
10
State Street
Massachusetts
– -$49.1M -2,278,301 Closed
Geode Capital Management
11
Geode Capital Management
Massachusetts
– -$46.5M -2,156,356 Closed
HCM
12
Highbridge Capital Management
New York
– -$44.1M -2,048,585 Closed
WE
13
Wealth Effects
Massachusetts
– -$40.8M -1,891,917 Closed
Janus Henderson Group
14
Janus Henderson Group
United Kingdom
– -$39.3M -1,823,865 Closed
PCM
15
Pentwater Capital Management
Florida
– -$36.3M -1,684,000 Closed
KCM
16
Kennedy Capital Management
Missouri
– -$25.7M -1,194,197 Closed
WIC
17
Water Island Capital
New York
– -$23.4M -1,087,117 Closed
KAM
18
Krensavage Asset Management
New York
– -$18.4M -855,860 Closed
Northern Trust
19
Northern Trust
Illinois
– -$17.2M -797,200 Closed
Charles Schwab
20
Charles Schwab
California
– -$17.1M -793,752 Closed
Hudson Bay Capital Management
21
Hudson Bay Capital Management
Connecticut
– -$16.9M -782,239 Closed
Citadel Advisors
22
Citadel Advisors
Florida
– -$16.6M -770,232 Closed
WP
23
Woodline Partners
California
– -$15.1M -702,066 Closed
Neuberger Berman Group
24
Neuberger Berman Group
New York
– -$14.7M -684,321 Closed
Goldman Sachs
25
Goldman Sachs
New York
– -$14.1M -655,058 Closed
1
2 3 4 5

AVDL Hedge Fund Activity: Q1 2026 in Review

2 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q1 2026, worth a combined $442 — down 100% from $1.6B a quarter earlier.

Sellers outnumbered buyers: 202 funds closed out of AVDL and 0 opened new positions — a net loss of 202 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $152M sold.

  • 2 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q1 2026, down from 207 in Q4 2025.
  • Funds reported $442 of Avadel Pharmaceuticals stock for Q1 2026, down 100% quarter-over-quarter.
  • 0 funds opened new Avadel Pharmaceuticals positions in Q1 2026 and 202 closed out, a net change of -202 holders.
  • The largest Avadel Pharmaceuticals seller in Q1 2026 was BlackRock, an estimated $152M sold.

Based on aggregated 13F filings for Q1 2026.